Response to “Acute and subacute sensorineural hearing loss after radiosurgery for vestibular schwannomas: Avoiding what is avoidable?”

Published:April 17, 2019DOI:https://doi.org/10.1016/j.jns.2019.04.024
      We thank Dr. Tuleasca and the colleagues' suggestion about our paper entitled “Acute sensorineural hearing loss in patients with vestibular schwannoma (VS) early after cyberknife radiosurgery” [
      • Wu C.H.
      • Chen C.M.
      • Cheng P.W.
      Young YH (2019). Acute sensorineural hearing loss in patients with vestibular schwannoma early after cyberknife radiosurgery.
      ]. They mentioned their experience about adverse radiation events (ARE) during the first months after gamma knife radiosurgery based on their paper published on the proceedings of the 18th international meeting of the Leksell gamma knife society [
      • Tuleasca C.
      • George M.
      • Faouzi M.
      • et al.
      Acute clinical adverse radiation effects after gamma knife surgery for vestibular schwannomas.
      ]. They reported that the incidence of ARE was 22% including vertigo, gait disturbance, exacerbation of pre-existing hearing loss, etc. The majority of their patients with acute sensorineural hearing loss following radiosurgery recovered after one-week steroid therapy. Thus, they expanded discussion on how to preserve hearing after radiosurgery.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wu C.H.
        • Chen C.M.
        • Cheng P.W.
        Young YH (2019). Acute sensorineural hearing loss in patients with vestibular schwannoma early after cyberknife radiosurgery.
        J. Neurol. Sci. 2019; 399: 30-35
        • Tuleasca C.
        • George M.
        • Faouzi M.
        • et al.
        Acute clinical adverse radiation effects after gamma knife surgery for vestibular schwannomas.
        J Neurosurg. 2016; : 73-82
        • Stachler R.J.
        • Chandrasekhar S.S.
        • Archer S.M.
        • et al.
        Clinical practice guideline: sudden hearing loss.
        Otolaryngol Head Neck Surg. 2012; 146: S1-35
        • Lin M.C.
        • Chen C.M.
        • Tseng H.M.
        • Xiao F.
        • Young Y.H.
        A proposed method to comprehensively define outcomes in acoustic tumor patients undergoing cyberknife management.
        Stereotactic Funct Neurosurg. 2013; 91: 177-185
        • Lin K.L.
        • Chen C.M.
        • Wang S.J.
        • Young Y.H.
        Correlating vestibular schwannoma size with vestibular-evoked myogenic potential (VEMP) results.
        Ear Hear. 2014; 35: 571-576
        • Massager N.
        • Nissim O.
        • Delbrouck C.
        • et al.
        Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome.
        J. Neurosurg. 2007; 107: 733-739
        • Kano H.
        • Kondziolka D.
        • Khan A.
        • Flickinger J.C.
        • Lunsford L.D.
        Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma.
        J. Neurosurg. 2009; 111: 863-873
        • Coleman J.K.
        • Kopke R.D.
        • Liu J.
        • et al.
        Pharmacological rescue of noise induced hearing loss using N-acetylcysteine and acetyl-L-carnitine.
        Hear. Res. 2007; 226: 104-113
        • Schuknecht H.F.
        • Donovan E.D.
        The pathology of idiopathic sudden sensorineural hearing loss.
        Arch Otorhinolaryngol. 1986; 243: 1-15
        • Hayden Gephart M.G.
        • Hansasuta A.
        • Balise R.R.
        • et al.
        Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma.
        World Neurosurg. 2013; 80: 359-363
        • Sakamoto T.
        • Shirato H.
        • Takeichi N.
        • et al.
        Medication for hearing loss after fractionated stereotactic radiotherapy (SRT) for vestibular schwannoma.
        Int. J. Radiat. Oncol. Biol. Phys. 2001; 50: 1295-1298